In the last trading session, 1.37 million Aehr Test Systems (NASDAQ:AEHR) shares changed hands as the company’s beta touched 2.05. With the company’s per share price at $15.68 changed hands at $0.89 or 6.02% during last session, the market valuation stood at $464.60M. AEHR’s last price was a discount, traded about -132.14% off its 52-week high of $36.40. The share price had its 52-week low at $9.83, which suggests the last value was 37.31% up since then. When we look at Aehr Test Systems’s average trading volume, we note the 10-day average is 2.54 million shares, with the 3-month average coming to 1.29 million.
Analysts gave the Aehr Test Systems (AEHR) stock a consensus recommendation rating of Buy, calculated at a mean rating of 2.00. If we narrow down to specifics, the data shows that 0 out of 1 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended AEHR as a Hold, 1 felt it is a Buy and 0 rated the stock as Underweight. Aehr Test Systems’s EPS for the current quarter is expected to be 0.03.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Aehr Test Systems (NASDAQ:AEHR) trade information
Instantly AEHR was in green as seen at the end of in last trading. With action -2.12%, the performance over the past five days has been red. The company’s shares are showing year-to-date downside of -40.90%, with the 5-day performance at -2.12% in the red. However, in the 30-day time frame, Aehr Test Systems (NASDAQ:AEHR) is 20.80% up. Looking at the short shares, we see there were 5.27 million shares sold at short interest cover period of 6.66 days.
The consensus price target for the stock as assigned by Wall Street analysts is 25, meaning bulls need an upside of 37.28% from its current market value. According to analyst projections, AEHR’s forecast low is 25 with 25 as the target high. To hit the forecast high, the stock’s price needs a -59.44% plunge from its current level, while the stock would need to soar -59.44% for it to hit the projected low.
Aehr Test Systems (AEHR) estimates and forecasts
Data shows that the Aehr Test Systems share is performing relatively much not better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value shot 51.35% over the past 6 months, a -74.38% in annual growth rate that is considerably lower than the industry average of -2.30%. Year-over-year growth is forecast to reach 7.00% up from the last financial year.
Consensus estimates given by 2 financial analysts project the company’s revenue in the current quarter to hit an average of 15.03M. 2 analysts are of the opinion that Aehr Test Systems’s revenue for the current quarter will be 19.67M.
The 2024 estimates are for Aehr Test Systems earnings to decrease by -64.71%, but the outlook for the next 5-year period is at 20.00% per year.
AEHR Dividends
Aehr Test Systems is expected to release its next quarterly earnings report in November.
Aehr Test Systems (NASDAQ:AEHR)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 5.65% of Aehr Test Systems shares while 66.45% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 70.43%. There are 66.45% institutions holding the Aehr Test Systems stock share, with VANGUARD GROUP INC the top institutional holder. As of 2024-06-30, the company held 7.2944% of the shares, roughly 2.11 million AEHR shares worth $23.52 million.
BLACKROCK INC. holds the second largest percentage of outstanding shares, with 6.5947% or 1.9 million shares worth $21.26 million as of 2024-06-30.
